The purpose of this study is to compare the safety and efficacy of letermovir with valganciclovir for prevention of Cytomegalovirus (CMV) viremia in moderate t…

CMV ViremiaHeart Transplant InfectionHeart Transplant Failure and Rejection

~Estimated

~$10 – $6,250

Columbia UniversityNCT07079735

Phase 1

Levothyroxine Supplementation for Heart Transplant Recipients: A Randomized Control Trial

This will be a prospective, randomized study performed at a single tertiary referral academic medical center (University of California San Francisco, CA), eval…

Heart Transplant FailureHeart Transplant Infection

~Estimated

~$10 – $5,625

University of California, San FranciscoNCT06428097

Phase 4

Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients

The investigators will evaluate for early evidence of cardiac allograft dysfunction by cardiac MRI and single cell sequencing to determine underlying molecular…

Heart Transplant Failure and Rejection

~Estimated

~$10 – $7,500

Paul KimNCT03102125